Home » Healthcare » Bovine Respiratory Diseases Market

Bovine Respiratory Diseases Market By Treatment Type (Vaccines, Antibiotics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Immunomodulators, Others); By Disease Type (Lower Respiratory Tract Infections, Upper Respiratory Tract Infections, Diphtheria); By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Private Veterinary Pharmacies, Veterinary Research Institutes) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Bovine Respiratory Diseases Market Size 2023	USD 2,301.98 Million
Bovine Respiratory Diseases Market, CAGR	5.50%
Bovine Respiratory Diseases Market Size 2032	USD 3,727.12 Million

Market Overview

The Bovine Respiratory Diseases market is projected to grow from USD 2,301.98 million in 2023 to an estimated USD 3,727.12 million by 2032, with a compound annual growth rate (CAGR) of 5.50% from 2024 to 2032. This significant growth is driven by the rising prevalence of respiratory diseases in cattle, increasing awareness among farmers regarding animal health, and the growing adoption of advanced veterinary services.

Key market drivers include the increasing demand for beef and dairy products, which fuels the need for maintaining healthy livestock populations. Additionally, advancements in veterinary diagnostics and therapeutics, along with rising government initiatives to improve animal healthcare, are contributing to the market’s growth. Trends such as the development of vaccines and antibiotics specifically targeting respiratory diseases in cattle are also gaining traction, reflecting the industry’s focus on preventive care.

Geographically, North America holds a dominant share of the bovine respiratory diseases market, followed by Europe, due to the well-established veterinary infrastructure and high awareness levels among farmers. The Asia-Pacific region is anticipated to exhibit the fastest growth during the forecast period, driven by the increasing cattle population and rising demand for veterinary services. Key players in this market include Zoetis Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, and Boehringer Ingelheim GmbH, which are actively engaged in research and development to introduce innovative products.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

Rising Prevalence of Bovine Respiratory Diseases

Bovine respiratory diseases (BRD) are a leading cause of morbidity and mortality in cattle populations worldwide, significantly impacting the profitability of the beef and dairy industries. The rising prevalence of these diseases is a key driver of the market, as farmers and livestock producers seek effective treatments to mitigate the economic losses associated with BRD. Several factors contribute to the increased incidence of BRD, including intensive farming practices, stress during transportation, and environmental factors like poor ventilation in cattle housing facilities. For instance, data from industry surveys indicate that BRD accounts for a substantial percentage of cattle deaths in feedlots. Government reports have also highlighted the economic impact of BRD on the livestock industry, with annual losses reaching significant figures. As the livestock industry continues to grow, especially in regions with intensive cattle farming, the demand for effective BRD management solutions is expected to rise, further driving market growth.

Increasing Awareness and Adoption of Veterinary Services

The growing awareness among farmers and livestock owners about the importance of animal health and the economic impact of diseases like BRD is another significant driver of the market. There is a clear understanding that the health of livestock directly correlates with productivity, and as a result, there is an increasing willingness to invest in veterinary services. The adoption of regular veterinary check-ups, vaccinations, and early disease detection methods has seen a notable increase. For example, surveys conducted by agricultural organizations have shown a rising trend in the utilization of veterinary services among cattle farmers. Furthermore, advancements in veterinary diagnostics have made it easier to identify respiratory diseases at an early stage, allowing for timely intervention. The development of point-of-care diagnostics and portable veterinary tools has also facilitated easier access to veterinary care, particularly in remote and rural areas. This heightened awareness and improved access to veterinary services are expected to continue driving the demand for BRD treatments and preventive solutions.

Government Initiatives and Support for Animal Health

Governments across the globe are recognizing the critical importance of animal health in ensuring food security and safety. Various government initiatives aimed at improving livestock health are playing a crucial role in driving the bovine respiratory diseases market. These initiatives include subsidies for vaccinations, funding for research and development in veterinary medicine, and the establishment of animal health monitoring programs. For instance, government reports indicate substantial allocations for livestock health programs in many countries. Such initiatives not only raise awareness about the importance of disease prevention but also provide financial support to farmers, enabling them to invest in better healthcare for their livestock. Additionally, government regulations mandating the vaccination of cattle against certain diseases are further driving the adoption of preventive measures in the livestock industry. Data from regulatory bodies show an increase in compliance with these mandates. This regulatory support is expected to sustain market growth by encouraging the widespread use of BRD prevention and treatment products.

Advancements in Veterinary Medicine and Technology

The field of veterinary medicine has seen significant advancements in recent years, particularly in the development of treatments and vaccines for bovine respiratory diseases. Innovations in biotechnology have led to the creation of more effective vaccines that offer longer-lasting immunity and better protection against a broader range of respiratory pathogens. Additionally, there has been a surge in the development of novel antibiotics and anti-inflammatory drugs specifically designed for cattle, improving the treatment outcomes for BRD. The use of precision medicine in veterinary care is also gaining momentum, with treatments being tailored to the specific needs of individual animals, leading to more effective disease management. Moreover, the integration of technology into veterinary care, such as the use of wearable devices for health monitoring and the application of artificial intelligence in diagnostics, is transforming the way respiratory diseases are managed in cattle. These technological advancements are making it possible to detect diseases at an earlier stage, predict outbreaks, and administer targeted treatments, all of which are expected to drive the growth of the bovine respiratory diseases market. As these innovations continue to evolve, they will likely lead to even more effective and efficient solutions for managing BRD, further fueling market expansion.

Market Trends

Shift Towards Preventive Healthcare and Vaccination Programs

A significant trend in the bovine respiratory diseases (BRD) market is the growing emphasis on preventive healthcare and vaccination programs. Livestock producers and veterinarians are increasingly prioritizing preventive measures over reactive treatments, recognizing that early intervention can significantly reduce the incidence of BRD and associated economic losses. This shift is driven by advancements in vaccine development, which have resulted in more effective and longer-lasting vaccines specifically designed to combat respiratory pathogens in cattle. For instance, data from industry surveys indicates a substantial increase in the adoption of comprehensive vaccination programs that target multiple diseases simultaneously. Government authorities have also reported a rise in the number of farms implementing regular vaccination schedules. As awareness of the benefits of preventive healthcare continues to grow, the demand for BRD vaccines and other preventive solutions is expected to increase further, shaping the future of the market.

Integration of Technology in Disease Management

The integration of technology into the management of bovine respiratory diseases is another prominent trend shaping the market. Innovations in veterinary diagnostics, such as the use of portable devices and advanced imaging technologies, are enabling earlier and more accurate detection of respiratory diseases in cattle. For example, surveys conducted by agricultural technology companies show a significant uptake in the use of wearable devices and sensors to monitor livestock health in real-time. Government reports also highlight an increasing trend in the adoption of data analytics and artificial intelligence (AI) for disease prediction and management. These technologies enable veterinarians and farmers to analyze large volumes of data, identify patterns, and predict potential outbreaks. Industry data suggests that farms utilizing these technologies have seen improvements in the efficiency of BRD management and reductions in treatment costs. As these technological innovations continue to evolve, they are expected to play an increasingly critical role in the management and prevention of bovine respiratory diseases.

Market Restraints and Challenges

High Costs of Treatment and Vaccination

One of the significant restraints in the bovine respiratory diseases (BRD) market is the high cost associated with treatment and prevention. The expenses involved in administering vaccines, purchasing antibiotics, and implementing comprehensive health management programs can be substantial, particularly for small and medium-sized livestock farms. For instance, data from the National Animal Health Monitoring System (NAHMS) Beef Feedlot study indicates that the direct cost of treating respiratory disease in feedlot cattle is considerable per case, not including indirect costs such as reduced performance and carcass value. While large-scale operations may absorb these costs, smaller farms often struggle to afford necessary treatments, leading to lower adoption rates of advanced veterinary solutions. This cost barrier can hinder widespread implementation of effective BRD management practices, impacting overall market growth. Additionally, the development and approval processes for new vaccines and treatments are lengthy and expensive, delaying the introduction of innovative products and limiting their availability to farmers.

Antibiotic Resistance and Regulatory Challenges

Another critical challenge in the BRD market is the growing concern over antibiotic resistance, which has become a significant issue in veterinary medicine. The overuse and misuse of antibiotics in livestock have led to the development of resistant strains of bacteria, reducing the effectiveness of conventional treatments for respiratory diseases. For example, surveys conducted by government authorities have shown an increase in antimicrobial resistance among common BRD pathogens over time. This not only poses a threat to animal health but also raises concerns about potential impacts on human health through transmission of resistant bacteria. Regulatory bodies are increasingly imposing restrictions on antibiotic use in livestock, limiting options for treating BRD. While necessary to combat resistance, these regulations present challenges for farmers and veterinarians seeking alternative disease management solutions. The need for stringent compliance with evolving regulatory frameworks, coupled with limited availability of effective non-antibiotic treatments, poses a significant challenge to BRD market growth. As the industry navigates these challenges, there is growing emphasis on developing new, sustainable treatment options that can effectively manage BRD without contributing to antibiotic resistance.

Market Segmentation Analysis

By Treatment Type

The treatment landscape for Bovine Respiratory Diseases (BRD) is diverse, with vaccines holding a significant market share. For instance, a recent survey by the USDA’s National Animal Health Monitoring System found that a large percentage of feedlots use respiratory vaccinations as part of their initial treatment protocol for BRD. Antibiotics remain vital, particularly for acute cases, with data showing that nearly all feedlots treating cattle for respiratory disease use injectable antibiotics. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are also widely used, with government reports indicating that over half of feedlots employ NSAIDs in their BRD treatment regimens. Immunomodulators are gaining momentum, aligning with the increasing focus on livestock immunity. A study published in the Journal of Veterinary Internal Medicine highlighted the potential of immunomodulators in reducing BRD morbidity. Alternative treatments, including herbal remedies and supportive therapies, are becoming more popular among farmers seeking natural approaches. This trend is supported by data from industry surveys showing a growing interest in holistic BRD management strategies among livestock producers.

By Disease Type

The Bovine Respiratory Diseases (BRD) market is primarily driven by the prevalence of lower respiratory tract infections. According to a comprehensive study published in the Journal of Veterinary Internal Medicine, lower respiratory tract infections represent the largest segment of BRD cases, often requiring intensive treatment. The National Animal Health Monitoring System’s Feedlot report underscores the economic impact of these infections, highlighting the substantial costs associated with treatment and productivity losses. Upper respiratory tract infections, while less severe, still necessitate prompt treatment. Industry data indicates a steady growth in this market segment, with many feedlots implementing early intervention strategies to prevent progression to more serious conditions. Diphtheria, though less common, remains a critical concern. A survey conducted by a leading animal health organization revealed that while diphtheria cases are relatively rare, they require immediate and intensive medical intervention. This has led to the development of specialized treatment protocols and a small but essential market segment for diphtheria-specific treatments in the BRD market.

Segments

Based on Treatment Type

Vaccines
Antibiotics
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Immunomodulators
Others

Based on Disease Type

Lower Respiratory Tract Infections
Upper Respiratory Tract Infections
Diphtheria

Based on Distribution Channel

Veterinary Hospitals
Veterinary Clinics
Private Veterinary Pharmacies
Veterinary Research Institutes

Based on Region

North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

Regional Analysis

Europe (28%):

Europe follows closely, with a market share of around 28%. The market is characterized by stringent regulations on animal health and welfare, driving adoption of effective BRD management practices. Key contributors include Germany, France, and the United Kingdom, supported by robust veterinary services and a focus on preventive healthcare. The region’s emphasis on sustainable agriculture and reducing antibiotic usage is pushing development of alternative treatments and vaccines. Overall, Europe’s strong regulatory environment and advanced veterinary infrastructure position it as a major player in the global BRD market.

Asia Pacific (22%):

The Asia-Pacific region is expected to witness the fastest growth in the BRD market, with a current market share of approximately 22%, driven by increasing cattle populations, rising demand for veterinary services, and growing awareness of livestock health among farmers. Countries like China, India, and Australia are leading this expansion, supported by government initiatives to improve animal health and investments in veterinary infrastructure. The region is also benefiting from adoption of advanced technologies in veterinary care, such as diagnostic tools and precision livestock farming. These factors, combined with the large and growing livestock sector in many Asian countries, make Asia-Pacific a key growth area for the BRD market going forward.

Key players

Bimeda
Boehringer Ingelheim GmbH
Ceva
Elanco
Merck & Co. Inc.
Vetoquinol
Vetoquinol
Zoetis Inc.
Bayer AG
IDEXX Laboratories
Indian Immunological Ltd
Orofino Saúde Animal

Competitive Analysis

The Bovine Respiratory Diseases (BRD) market is highly competitive, with key players like Zoetis Inc., Merck & Co. Inc., and Boehringer Ingelheim GmbH leading the industry due to their extensive product portfolios and strong global presence. These companies focus heavily on research and development to introduce innovative treatments and vaccines, maintaining their competitive edge. Ceva, Elanco, and Bayer AG are also prominent players, leveraging their comprehensive veterinary solutions and strategic partnerships to expand their market reach. Emerging companies like Indian Immunological Ltd and Orofino Saúde Animal are gaining traction in regional markets, particularly in Asia-Pacific and Latin America, by offering cost-effective solutions tailored to local needs. The market is characterized by ongoing product innovation, strategic collaborations, and efforts to address challenges such as antibiotic resistance, which drive competition among established and emerging players alike.

Recent Developments

In September 2024, Boehringer Ingelheim acquired Saiba Animal Health, adding an innovative technology platform to its pet therapeutics R&D portfolio. While this acquisition is not directly related to BRD, it demonstrates the company’s ongoing investment in animal health innovation.
In May 2024, Elanco received FDA approval for Pradalex, a prescription-only single-injection antimicrobial for the treatment of certain respiratory diseases in cattle and swine. This is the first new molecule and injectable antibiotic treatment to be approved in more than a decade.
In June 2024, Merck Animal Health announced USDA approval of NOBIVAC, an innovative technology representing a breakthrough scientific achievement for a highly contagious respiratory disease. While the specific disease is not mentioned, this approval demonstrates Merck’s ongoing efforts in addressing respiratory diseases in animals.

Market Concentration and Characteristics

The Bovine Respiratory Diseases (BRD) market is characterized by moderate to high market concentration, with several key players dominating the industry. Companies such as Zoetis Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, and Boehringer Ingelheim GmbH hold significant market shares, driven by their extensive product portfolios, strong research and development capabilities, and global distribution networks. The market is also marked by a high degree of innovation, with continuous advancements in vaccine development, antibiotics, and diagnostic tools. While larger players lead the market, there is also a presence of smaller, regional companies that focus on niche segments or alternative treatment options, contributing to the market’s competitive dynamics. The market’s growth is further supported by increasing investments in veterinary healthcare and the rising emphasis on preventive measures, which are essential in managing the widespread impact of BRD on the global cattle industry.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Report Coverage

The research report offers an in-depth analysis based on Treatment Type, Disease Type, Distribution Channel and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The future of the BRD market will see a significant rise in the adoption of comprehensive vaccination programs, as farmers and veterinarians increasingly prioritize prevention over treatment to reduce economic losses.
Innovations in vaccine development, including the creation of more effective and longer-lasting vaccines, will drive the market, offering better protection against a broader range of respiratory pathogens.
As concerns over antibiotic resistance grow, there will be a shift towards immunomodulators and alternative therapies, providing safer and more sustainable options for managing BRD in cattle.
The integration of telemedicine in veterinary care will expand, allowing for remote diagnosis and monitoring of BRD, particularly in rural and underserved regions, improving access to timely treatment.
Precision livestock farming technologies, such as wearable health monitors and data analytics, will gain traction, enabling early detection and more targeted management of BRD outbreaks.
Government initiatives and supportive regulatory frameworks will continue to play a crucial role in driving market growth by encouraging vaccination and funding research in veterinary medicine.
Emerging markets, particularly in Asia-Pacific and Latin America, will witness robust growth in the BRD market due to increasing cattle populations and growing investments in veterinary infrastructure.
The future will see the development and adoption of combination therapies that target multiple respiratory pathogens simultaneously, offering more comprehensive protection for livestock.
Collaborations between pharmaceutical companies, research institutions, and universities will intensify, leading to accelerated innovation and the development of new treatment solutions for BRD.
There will be a growing emphasis on sustainable practices in BRD management, including the reduction of antibiotic use and the adoption of environmentally friendly treatment methods, aligning with global trends towards sustainable agriculture.

CHAPTER NO. 1 , INTRODUCTION 22
1.1.1. Report Description 22
Purpose of the Report 22
USP & Key Offerings 22
1.1.2. Key Benefits for Stakeholders 22
1.1.3. Target Audience 23
1.1.4. Report Scope 23
CHAPTER NO. 2 , EXECUTIVE SUMMARY 24
2.1. Bovine Respiratory Disease Treatment Market Snapshot 24
2.1.1. Global Bovine Respiratory Disease Treatment Market, 2018 – 2032 (USD Million) 25
CHAPTER NO. 3 , GEOPOLITICAL CRISIS IMPACT ANALYSIS 26
3.1. Russia-Ukraine and Israel-Palestine War Impacts 26
CHAPTER NO. 4 , BOVINE RESPIRATORY DISEASE TREATMENT MARKET – INDUSTRY ANALYSIS 27
4.1. Introduction 27
4.2. Market Drivers 28
4.2.1. Driving Factor 1 Analysis 28
4.2.2. Driving Factor 2 Analysis 29
4.3. Market Restraints 30
4.3.1. Restraining Factor Analysis 30
4.4. Market Opportunities 31
4.4.1. Market Opportunity Analysis 31
4.5. Porter’s Five Forces Analysis 32
CHAPTER NO. 5 , ANALYSIS COMPETITIVE LANDSCAPE 33
5.1. Company Market Share Analysis – 2023 33
5.1.1. Global Bovine Respiratory Disease Treatment Market, Company Market Share, by Volume, 2023 33
5.1.2. Global Bovine Respiratory Disease Treatment Market, Company Market Share, by Revenue, 2023 34
5.1.3. Global Bovine Respiratory Disease Treatment Market, Top 6 Company Market Share, by Revenue, 2023 34
5.1.4. Global Bovine Respiratory Disease Treatment Market, Top 3 Company Market Share, by Revenue, 2023 35
5.2. Global Bovine Respiratory Disease Treatment Market Company Revenue Market Share, 2023 36
5.3. Company Assessment Metrics, 2023 37
5.3.1. Stars 37
5.3.2. Emerging Leaders 37
5.3.3. Pervasive Players 37
5.3.4. Participants 37
5.4. Start-ups /SMEs Assessment Metrics, 2023 37
5.4.1. Progressive Companies 37
5.4.2. Responsive Companies 37
5.4.3. Dynamic Companies 37
5.4.4. Starting Blocks 37
5.5. Strategic Developments 38
5.5.1. Acquisitions & Mergers 38
New Product Launch 38
Global Expansion 38
5.6. Key Players Product Matrix 39
CHAPTER NO. 6 , PESTEL & ADJACENT MARKET ANALYSIS 40
6.1. PESTEL 40
6.1.1. Political Factors 40
6.1.2. Economic Factors 40
6.1.3. Social Factors 40
6.1.4. Technological Factors 40
6.1.5. Environmental Factors 40
6.1.6. Legal Factors 40
6.2. Adjacent Market Analysis 40
CHAPTER NO. 7 , BOVINE RESPIRATORY DISEASE TREATMENT MARKET – BY TREATMENT TYPE SEGMENT ANALYSIS 41
7.1. Bovine Respiratory Disease Treatment Market Overview, by Treatment Type Segment 41
7.1.1. Bovine Respiratory Disease Treatment Market Revenue Share, By Treatment Type, 2023 & 2032 42
7.1.2. Bovine Respiratory Disease Treatment Market Attractiveness Analysis, By Treatment Type 43
7.1.3. Incremental Revenue Growth Opportunity, by Treatment Type, 2024 – 2032 43
7.1.4. Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 44
7.2. Vaccines 45
7.3. Antibiotics 46
7.4. NSAIDs 47
7.5. Immunomodulators 48
7.6. Others 49
CHAPTER NO. 8 , BOVINE RESPIRATORY DISEASE TREATMENT MARKET – BY DISEASE TYPE SEGMENT ANALYSIS 50
8.1. Bovine Respiratory Disease Treatment Market Overview, by Disease Type Segment 50
8.1.1. Bovine Respiratory Disease Treatment Market Revenue Share, By Disease Type, 2023 & 2032 51
8.1.2. Bovine Respiratory Disease Treatment Market Attractiveness Analysis, By Disease Type 52
8.1.3. Incremental Revenue Growth Opportunity, by Disease Type, 2024 – 2032 52
8.1.4. Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018, 2023, 2027 & 2032 53
8.2. Lower Respiratory Tract 54
8.3. Upper Respiratory Tract Infections 55
8.4. Diphtheria 56
CHAPTER NO. 9 , BOVINE RESPIRATORY DISEASE TREATMENT MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 57
9.1. Bovine Respiratory Disease Treatment Market Overview, by Distribution Channel Segment 57
9.1.1. Bovine Respiratory Disease Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 58
9.1.2. Bovine Respiratory Disease Treatment Market Attractiveness Analysis, By Distribution Channel 59
9.1.3. Incremental Revenue Growth Opportunity, by Distribution Channel, 2024 – 2032 59
9.1.4. Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 60
9.2. Veterinary Hospital 61
9.3. Veterinary Clinics 62
9.4. Private Veterinary Pharmacies 63
9.5. Veterinary Research Institutes 64
CHAPTER NO. 10 , BOVINE RESPIRATORY DISEASE TREATMENT MARKET – GLOBAL ANALYSIS 65
10.1. Treatment Type 65
10.1.1. Global Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 65
10.2. Global Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 65
10.3. Disease Type 66
10.3.1. Global Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 66
10.3.2. Global Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2024 – 2032 (USD Million) 66
10.4. Distribution Channel 67
10.4.1. Global Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 67
10.4.2. Global Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 67
CHAPTER NO. 11 , BOVINE RESPIRATORY DISEASE TREATMENT MARKET – NORTH AMERICA 68
11.1. North America 68
11.1.1. Key Highlights 68
11.1.2. North America Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 69
11.1.3. North America Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 70
11.1.4. North America Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 71
11.1.5. North America Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 72
11.2. U.S. 73
11.3. Canada 73
11.4. Mexico 73
CHAPTER NO. 12 , BOVINE RESPIRATORY DISEASE TREATMENT MARKET – EUROPE 74
12.1. Europe 74
12.1.1. Key Highlights 74
12.1.2. Europe Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 75
12.1.3. Europe Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 76
12.1.4. Europe Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 77
12.1.5. Europe Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 78
12.2. UK 79
12.3. France 79
12.4. Germany 79
12.5. Italy 79
12.6. Spain 79
12.7. Russia 79
12.8. Belgium 79
12.9. Netherland 79
12.10. Austria 79
12.11. Sweden 79
12.12. Poland 79
12.13. Denmark 79
12.14. Switzerland 79
12.15. Rest of Europe 79
CHAPTER NO. 13 , BOVINE RESPIRATORY DISEASE TREATMENT MARKET – ASIA PACIFIC 80
13.1. Asia Pacific 80
13.1.1. Key Highlights 80
13.1.2. Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 81
13.1.3. Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 82
13.1.4. Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 83
13.1.5. Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 84
13.2. China 85
13.3. Japan 85
13.4. South Korea 85
13.5. India 85
13.6. Australia 85
13.7. Thailand 85
13.8. Indonesia 85
13.9. Vietnam 85
13.10. Malaysia 85
13.11. Philippines 85
13.12. Taiwan 85
13.13. Rest of Asia Pacific 85
CHAPTER NO. 14 , BOVINE RESPIRATORY DISEASE TREATMENT MARKET – LATIN AMERICA 86
14.1. Latin America 86
14.1.1. Key Highlights 86
14.1.2. Latin America Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 87
14.1.3. Latin America Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 88
14.1.4. Latin America Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 89
14.1.5. Latin America Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 90
14.2. Brazil 91
14.3. Argentina 91
14.4. Peru 91
14.5. Chile 91
14.6. Colombia 91
14.7. Rest of Latin America 91
CHAPTER NO. 15 , BOVINE RESPIRATORY DISEASE TREATMENT MARKET – MIDDLE EAST 92
15.1. Middle East 92
15.1.1. Key Highlights 92
15.1.2. Middle East Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 93
15.1.3. Middle East Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 94
15.1.4. Middle East Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 95
15.1.5. Middle East Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 96
15.2. UAE 97
15.3. KSA 97
15.4. Israel 97
15.5. Turkey 97
15.6. Iran 97
15.7. Rest of Middle East 97
CHAPTER NO. 16 , BOVINE RESPIRATORY DISEASE TREATMENT MARKET – AFRICA 98
16.1. Africa 98
16.1.1. Key Highlights 98
16.1.2. Africa Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 99
16.1.3. Africa Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 100
16.1.4. Africa Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 101
16.1.5. Africa Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 102
16.2. Egypt 103
16.3. Nigeria 103
16.4. Algeria 103
16.5. Morocco 103
16.6. Rest of Africa 103
CHAPTER NO. 17 , COMPANY PROFILES 104
17.1. Bimeda 104
17.1.1. Company Overview 104
17.1.2. Product Portfolio 104
17.1.3. Swot Analysis 104
17.1.4. Business Strategy 105
17.1.5. Financial Overview 105
17.2. Boehringer Ingelheim GmbH 106
17.3. Ceva 106
17.4. Elanco 106
17.5. Merck & Co. Inc. 106
17.6. Veto quinol 106
17.7. Vribac 106
17.8. Zoetis Inc. 106
17.9. Bayer AG 106
17.10. Idexx laboratories 106
17.11. Indian Immunological Ltd 106
17.12. Orofino Saude Animal 106
CHAPTER NO. 18 , RESEARCH METHODOLOGY 107
18.1. Research Methodology 107
18.1.1. Phase I – Secondary Research 108
18.1.2. Phase II – Data Modeling 108
Company Share Analysis Model 109
Revenue Based Modeling 109
18.1.3. Phase III – Primary Research 110
18.1.4. Research Limitations 111
Assumptions 111

List of Figures
FIG NO. 1. Global Bovine Respiratory Disease Treatment Market Revenue, 2018 – 2032 (USD Million) 24
FIG NO. 2. Porter’s Five Forces Analysis for Global Bovine Respiratory Disease Treatment Market 31
FIG NO. 3. Company Share Analysis, 2023 32
FIG NO. 4. Company Share Analysis, 2023 33
FIG NO. 5. Company Share Analysis, 2023 33
FIG NO. 6. Company Share Analysis, 2023 34
FIG NO. 7. Bovine Respiratory Disease Treatment Market – Company Revenue Market Share, 2023 35
FIG NO. 8. Bovine Respiratory Disease Treatment Market Revenue Share, By Treatment Type, 2023 & 2032 41
FIG NO. 9. Market Attractiveness Analysis, By Treatment Type 42
FIG NO. 10. Incremental Revenue Growth Opportunity by Treatment Type, 2024 – 2032 42
FIG NO. 11. Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 43
FIG NO. 12. Global Bovine Respiratory Disease Treatment Market for Vaccines, Revenue (USD Million) 2018 – 2032 44
FIG NO. 13. Global Bovine Respiratory Disease Treatment Market for Antibiotics, Revenue (USD Million) 2018 – 2032 45
FIG NO. 14. Global Bovine Respiratory Disease Treatment Market for NSAIDs, Revenue (USD Million) 2018 – 2032 46
FIG NO. 15. Global Bovine Respiratory Disease Treatment Market for Immunomodulators, Revenue (USD Million) 2018 – 2032 47
FIG NO. 16. Global Bovine Respiratory Disease Treatment Market for Others, Revenue (USD Million) 2018 – 2032 48
FIG NO. 17. Bovine Respiratory Disease Treatment Market Revenue Share, By Disease Type, 2023 & 2032 50
FIG NO. 18. Market Attractiveness Analysis, By Disease Type 51
FIG NO. 19. Incremental Revenue Growth Opportunity by Disease Type, 2024 – 2032 51
FIG NO. 20. Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018, 2023, 2027 & 2032 52
FIG NO. 21. Global Bovine Respiratory Disease Treatment Market for Lower Respiratory Tract, Revenue (USD Million) 2018 – 2032 53
FIG NO. 22. Global Bovine Respiratory Disease Treatment Market for Upper Respiratory Tract Infections, Revenue (USD Million) 2018 – 2032 54
FIG NO. 23. Global Bovine Respiratory Disease Treatment Market for Diphtheria, Revenue (USD Million) 2018 – 2032 55
FIG NO. 24. Bovine Respiratory Disease Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 57
FIG NO. 25. Market Attractiveness Analysis, By Distribution Channel 58
FIG NO. 26. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 58
FIG NO. 27. Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 59
FIG NO. 28. Global Bovine Respiratory Disease Treatment Market for Veterinary Hospital, Revenue (USD Million) 2018 – 2032 60
FIG NO. 29. Global Bovine Respiratory Disease Treatment Market for Veterinary Clinics, Revenue (USD Million) 2018 – 2032 61
FIG NO. 30. Global Bovine Respiratory Disease Treatment Market for Private Veterinary Pharmacies, Revenue (USD Million) 2018 – 2032 62
FIG NO. 31. Global Bovine Respiratory Disease Treatment Market for Veterinary Research Institutes, Revenue (USD Million) 2018 – 2032 63
FIG NO. 32. North America Bovine Respiratory Disease Treatment Market Revenue, 2018 – 2032 (USD Million) 67
FIG NO. 33. Europe Bovine Respiratory Disease Treatment Market Revenue, 2018 – 2032 (USD Million) 73
FIG NO. 34. Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, 2018 – 2032 (USD Million) 79
FIG NO. 35. Latin America Bovine Respiratory Disease Treatment Market Revenue, 2018 – 2032 (USD Million) 85
FIG NO. 36. Middle East Bovine Respiratory Disease Treatment Market Revenue, 2018 – 2032 (USD Million) 91
FIG NO. 37. Africa Bovine Respiratory Disease Treatment Market Revenue, 2018 – 2032 (USD Million) 97
FIG NO. 38. Research Methodology – Detailed View 106
FIG NO. 39. Research Methodology 107

List of Tables
TABLE NO. 1. , Global Bovine Respiratory Disease Treatment Market, Snapshot 22
TABLE NO. 2. , Drivers for the Bovine Respiratory Disease Treatment Market, Impact Analysis 26
TABLE NO. 3. , Restraints for the Bovine Respiratory Disease Treatment Market, Impact Analysis 28
TABLE NO. 4. , Global Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 63
TABLE NO. 5. , Global Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 63
TABLE NO. 6. , Global Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 64
TABLE NO. 7. , Global Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2024 – 2032 (USD Million) 64
TABLE NO. 8. , Global Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 65
TABLE NO. 9. , Global Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 65
TABLE NO. 10. , North America Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 67
TABLE NO. 11. , North America Bovine Respiratory Disease Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 67
TABLE NO. 12. , North America Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 68
TABLE NO. 13. , North America Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 68
TABLE NO. 14. , North America Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 69
TABLE NO. 15. , North America Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2024 – 2032 (USD Million) 69
TABLE NO. 16. , North America Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 70
TABLE NO. 17. , North America Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 70
TABLE NO. 18. , Europe Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 73
TABLE NO. 19. , Europe Bovine Respiratory Disease Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 73
TABLE NO. 20. , Europe Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 74
TABLE NO. 21. , Europe Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 74
TABLE NO. 22. , Europe Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 75
TABLE NO. 23. , Europe Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2024 – 2032 (USD Million) 75
TABLE NO. 24. , Europe Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 76
TABLE NO. 25. , Europe Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 76
TABLE NO. 26. , Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 79
TABLE NO. 27. , Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 79
TABLE NO. 28. , Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 80
TABLE NO. 29. , Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 80
TABLE NO. 30. , Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 81
TABLE NO. 31. , Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2024 – 2032 (USD Million) 81
TABLE NO. 32. , Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 82
TABLE NO. 33. , Asia Pacific Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 82
TABLE NO. 34. , Latin America Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 85
TABLE NO. 35. , Latin America Bovine Respiratory Disease Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 85
TABLE NO. 36. , Latin America Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 86
TABLE NO. 37. , Latin America Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 86
TABLE NO. 38. , Latin America Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 87
TABLE NO. 39. , Latin America Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2024 – 2032 (USD Million) 87
TABLE NO. 40. , Latin America Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 88
TABLE NO. 41. , Latin America Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 88
TABLE NO. 42. , Middle East Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 91
TABLE NO. 43. , Middle East Bovine Respiratory Disease Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 91
TABLE NO. 44. , Middle East Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 92
TABLE NO. 45. , Middle East Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 92
TABLE NO. 46. , Middle East Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 93
TABLE NO. 47. , Middle East Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2024 – 2032 (USD Million) 93
TABLE NO. 48. , Middle East Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 94
TABLE NO. 49. , Middle East Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 94
TABLE NO. 50. , Africa Bovine Respiratory Disease Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 97
TABLE NO. 51. , Africa Bovine Respiratory Disease Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 97
TABLE NO. 52. , Africa Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 98
TABLE NO. 53. , Africa Bovine Respiratory Disease Treatment Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 98
TABLE NO. 54. , Africa Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2018 – 2023 (USD Million) 99
TABLE NO. 55. , Africa Bovine Respiratory Disease Treatment Market Revenue, By Disease Type, 2024 – 2032 (USD Million) 99
TABLE NO. 56. , Africa Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 100
TABLE NO. 57. , Africa Bovine Respiratory Disease Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 100

Frequently Asked Questions:

What is the projected growth of the Bovine Respiratory Diseases market?

The Bovine Respiratory Diseases market is expected to grow from USD 2,301.98 million in 2023 to USD 3,727.12 million by 2032, with a CAGR of 5.50% from 2024 to 2032.

What are the key drivers of the BRD market?

Key drivers include the rising prevalence of respiratory diseases in cattle, increasing awareness of animal health among farmers, and the adoption of advanced veterinary services.

Which region holds the largest market share in the BRD market?

North America holds the largest market share at approximately 35%, driven by a well-established livestock industry and advanced veterinary infrastructure.

How is technology influencing the BRD market?

Technology is playing a critical role by enabling early detection, precise disease management, and the development of more effective vaccines and treatment options.

Who are the major players in the Bovine Respiratory Diseases market?

Major players include Zoetis Inc., Merck & Co. Inc., Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, and Bayer AG, among others.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –